Moderna, Inc.는 미국, 유럽 및 해외에서 메신저 RNA 의약품을 제공하는 생명공학 기업입니다. 이 회사는 spikevax, mNEXSPIKE, mRESVIA를 포함한 호흡기 백신, 거대세포 바이러스 백신을 포함한 잠복 바이러스 백신, 노로바이러스를 포함한 장 바이러스 백신, 지카 백신을 포함한 공중 보건 백신, 라임 백신을 포함한 세균성 질병 백신을 제공합니다.
또한 Moderna, Inc.는 intismeran autogene을 포함한 종양학 치료제와 프로피온산 및 메틸말론산 혈증을 포함한 희귀 질환 제품을 제공합니다. 이 회사는 Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, OpenAI 등과 전략적 제휴 및 협력을 맺고 있습니다.
영어 원문 보기
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
